Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia

NCT00056004 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer
Lung Cancer

Interventions

DRUG: zileuton

Sponsor

Barbara Ann Karmanos Cancer Institute

Collaborators

[object Object]